Armata Pharmaceuticals (ARMP) Total Debt (2018 - 2026)
Armata Pharmaceuticals (ARMP) posted Total Debt of $88.0 million for Q1 2026, down 14.64% sequentially from $103.1 million in Q4 2025, and up 217.67% YoY from $27.7 million in Q1 2025.
Armata Pharmaceuticals (ARMP) Total Debt (2018 - 2026) Analysis & Trends
Armata Pharmaceuticals has reported Total Debt for 7 years, with the latest figure at $88.0 million in Q1 2026.
- Quarterly Total Debt rose 217.67% year-over-year to $88.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $88.0 million (up 217.67% YoY) and the FY2025 annual result came in at $103.1 million, up 357.26% from the prior year.
- Total Debt eased to $88.0 million in Q1 2026 per ARMP's latest filing, from $103.1 million in the prior quarter.
- Over five years, Total Debt peaked at $107.0 million in Q1 2024 and troughed at $22.3 million in Q3 2023.
- A 4-year average of $52.8 million and a median of $41.4 million in 2024 frame the typical range for Total Debt.
- The widest YoY moves for Total Debt: up 357.26% in 2025, down 74.12% in 2025.
- Over 4 years, Total Debt stood at $23.7 million in 2023, then retreated by 4.79% to $22.5 million in 2024, then surged by 357.26% to $103.1 million in 2025, then declined by 14.64% to $88.0 million in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $88.0 million, $103.1 million, and $63.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 9.34 Bn |
| 10 | Armata Pharmaceuticals | 178.96 Mn | 154.96 Mn | - | 205.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 205.93 Mn |
| Mar 31, 2026 | 87.98 Mn |
| Dec 31, 2025 | 103.06 Mn |
| Sep 30, 2025 | 63.33 Mn |
| Jun 30, 2025 | 33.45 Mn |
| Mar 31, 2025 | 27.69 Mn |
| Dec 31, 2024 | 22.54 Mn |
| Sep 30, 2024 | 41.36 Mn |
| Jun 30, 2024 | 48.26 Mn |
| Mar 31, 2024 | 107.03 Mn |
| Dec 31, 2023 | 23.67 Mn |
| Sep 30, 2023 | 22.28 Mn |
| Dec 31, 2020 | 1.94 Mn |
| Sep 30, 2020 | 1.77 Mn |
| Jun 30, 2020 | 1.62 Mn |
| Mar 31, 2020 | 1.48 Mn |
| Dec 31, 2019 | 970,000.00 |
| Sep 30, 2019 | 885,000.00 |
| Jun 30, 2019 | 769,000.00 |
| Dec 31, 2018 | 970,000.00 |